Literature DB >> 3735088

Methods for in vitro percutaneous absorption studies. VI: Preparation of the barrier layer.

R L Bronaugh, R F Stewart.   

Abstract

The skin membrane for in vitro percutaneous absorption studies was prepared so that it was similar in thickness to the in vivo barrier layer. A dermatome section from the skin surface produced a layer of skin that included the epidermis and papillary dermis (location of capillary loops) but without most of the dermal tissue. Improved absorption measurements were then obtained with hydrophobic compounds with the use of a polyethylene glycol 20 oleyl ether (PEG-20 oleyl ether) receptor fluid. With the haired rat, preparing a skin section 300-micron thick (and pretesting for damage to the barrier with H3-water) resulted in a membrane that gave values in good agreement with in vivo results for 3-phenyl-2-propenyl 2-aminobenzoate (cinnamyl anthranilate) (1) and benzo(a)pyrene absorption. When sparsely haired fuzzy rat skin was used, a section of skin 200-micron thick could be prepared without the need for pretesting for damage. Good agreement was obtained between in vivo and in vitro values for 1-(3-ethyl-5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)etha none (acetyl ethyl tetramethyl tetralin) (2) and DDT with 0.5% PEG-20 oleyl ether in water as the receptor fluid. The skin of the fuzzy rat seemed more similar in permeability to human skin than did the skin of the hairless mouse when the absorption of six compounds was compared.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3735088     DOI: 10.1002/jps.2600750513

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  15 in total

1.  In vivo percutaneous absorption: a key role for stratum corneum/vehicle partitioning.

Authors:  A Rougier; M Rallis; P Krien; C Lotte
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  The bioavailability of dermatological and other topically administered drugs.

Authors:  R H Guy; A H Guy; H I Maibach; V P Shah
Journal:  Pharm Res       Date:  1986-10       Impact factor: 4.200

3.  Development and evaluation of curcumin-loaded elastic vesicles as an effective topical anti-inflammatory formulation.

Authors:  Rumjhum Agrawal; Simarjot Kaur Sandhu; Ikksheta Sharma; Indu Pal Kaur
Journal:  AAPS PharmSciTech       Date:  2014-10-16       Impact factor: 3.246

4.  Estimating Maximal In Vitro Skin Permeation Flux from Studies Using Non-sink Receptor Phase Conditions.

Authors:  Shereen Yousef; Xin Liu; Ahmed Mostafa; Yousuf Mohammed; Jeffrey E Grice; Yuri G Anissimov; Wedad Sakran; Michael S Roberts
Journal:  Pharm Res       Date:  2016-06-16       Impact factor: 4.200

5.  Enhanced in vitro skin permeation of cationic drugs.

Authors:  P G Green; J Hadgraft; G Ridout
Journal:  Pharm Res       Date:  1989-07       Impact factor: 4.200

6.  Improving the sensitivity of in vitro skin penetration experiments.

Authors:  G B Kasting; T G Filloon; W R Francis; M P Meredith
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

7.  Transdermal delivery of levonorgestrel. V. Preparation of devices and evaluation in vitro.

Authors:  D R Friend; P Catz; J Heller; M Okagaki
Journal:  Pharm Res       Date:  1989-11       Impact factor: 4.200

8.  Influence of d-limonene on the transdermal penetration of felodipine.

Authors:  I Diez; C Peraire; R Obach; J Domenech
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1998 Jan-Mar       Impact factor: 2.441

9.  In vivo and in vitro analysis of skin penetration enhancement based on a two-layer diffusion model with polar and nonpolar routes in the stratum corneum.

Authors:  F Yamashita; H Bando; Y Koyama; S Kitagawa; Y Takakura; M Hashida
Journal:  Pharm Res       Date:  1994-02       Impact factor: 4.200

10.  In vitro human skin permeation of endoxifen: potential for local transdermal therapy for primary prevention and carcinoma in situ of the breast.

Authors:  Oukseub Lee; David Ivancic; Robert T Chatterton; Alfred W Rademaker; Seema A Khan
Journal:  Breast Cancer (Dove Med Press)       Date:  2011-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.